Innovation Breathes Here

Leading nonclinical CRO with highly customizable and diverse repertoire of toxicology services to accelerate your drug to market success

About Us

Vectura Fertin Pharma Laboratories is a Singapore-based nonclinical Contract Research Organisation (CRO) conducting nonclinical safety assessment studies. We are a Good Laboratory Practices (GLP) compliant and Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) accredited nonclinical testing facility.

Specializing in aerosol sciences and inhalation toxicology, and with more than 14 years of nonclinical research experience, we are in a unique position to offer pharmaceutical and biotech clients a diverse repertoire of highly customized laboratory services ranging from proof-of-concept to GLP-compliant studies.

Services

Inhalation Toxicology and Aerosol Sciences

GLP inhalation toxicology studies are at the core of our expertise.

Nonclinical Safety Assessments

Our studies are conducted in accordance to GLP standards and internationally accepted guidelines.

In Vitro Toxicology

Vectura Fertin Pharma Laboratories has established and validated assays for in vitro safety assessment of novel chemical entities or biologics.

Animal Disease Models

Our range of in vivo disease models include emphysema, chronic obstructive pulmonary disease (COPD), cardiovascular disease, cough, pulmonary fibrosis, etc.

Research Support Services

Our agility in providing end-to-end laboratory solutions also means that Vectura Fertin Pharma Laboratories can be your partner at any point of your preclinical journey through our a la carte services.

Simplify your Drug Development Journey

Supporting Your Nonclinical Program From Early Development To Market

Events & Conferences

At Vectura Fertin Pharma Laboratories, your research goals are our priority